Wisconsin Technology Today
SEE OTHER BRANDS

Exploring the science and technology news of Wisconsin

Wisconsin Technology Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Wisconsin Technology Today.

Press releases published on July 1, 2025

Zscaler Announces Pricing of $1.5 Billion Offering of 0.00% Convertible Senior Notes Due 2028

Zscaler Announces Pricing of $1.5 Billion Offering of 0.00% Convertible Senior Notes Due 2028

SAN JOSE, Calif., June 30, 2025 (GLOBE NEWSWIRE) -- Zscaler, Inc. (Nasdaq: ZS) today announced the pricing of $1.5 billion aggregate principal amount of 0.00% convertible senior notes due 2028 (the “notes”) in a private offering to persons reasonably …

NetAlly Launches AllyWare v2.8 Software Update, Delivering Enhanced Performance and Additional Wi-Fi 7 Visibility to Network Testers

NetAlly Launches AllyWare v2.8 Software Update, Delivering Enhanced Performance and Additional Wi-Fi 7 Visibility to Network Testers

COLORADO SPRINGS, Colo., July 01, 2025 (GLOBE NEWSWIRE) -- NetAlly, a leading innovator in handheld network testing solutions, today announced the release of AllyWare™ v2.8, the latest software update across its award-winning line of network testers, …

Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants

Rakovina Therapeutics Announces Intention to Amend Debentures and Warrants

VANCOUVER, British Columbia, June 30, 2025 (GLOBE NEWSWIRE) -- Rakovina Therapeutics Inc. (TSXV: RKV) (the “Company”) announces that it will apply to the TSX Venture Exchange (the “Exchange”) to amend the terms of certain outstanding warrants and …

Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock

Dyne Therapeutics Announces Pricing of $200.0 Million Public Offering of Common Stock

WALTHAM, Mass., June 30, 2025 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage company focused on delivering functional improvement for people living with genetically driven neuromuscular diseases, today announced the pricing of …

Acceleware Announces Non-Brokered Private Placement of Units and Shares for Debt Transactions

Acceleware Announces Non-Brokered Private Placement of Units and Shares for Debt Transactions

CALGARY, Alberta, June 30, 2025 (GLOBE NEWSWIRE) -- Acceleware® Ltd. (“Acceleware” or the “Company”) (TSX-V: AXE), a leading innovator of cutting-edge radio frequency (“RF”) power-to-heat technologies targeting process heat for critical minerals, amine …

Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure

Mesoblast and FDA Align on Key Items for Revascor® Biologic License Application in Ischemic Heart Failure

NEW YORK, June 30, 2025 (GLOBE NEWSWIRE) -- Mesoblast (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today announced alignment with the United States Food and Drug Administration (FDA) on items required …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service